Literature DB >> 6175994

Interferons: biochemical, cell growth inhibitory, and immunological effects.

E C Borden, L A Ball.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6175994

Source DB:  PubMed          Journal:  Prog Hematol        ISSN： 0079-6301


× No keyword cloud information.
  15 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.

Authors:  O Kloke; R Becher; N Niederle
Journal:  Blut       Date:  1987-11

3.  The effect of treatment with interferon-gamma on type II collagen-induced arthritis.

Authors:  H Nakajima; H Takamori; Y Hiyama; W Tsukada
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

4.  Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.

Authors:  S N Giri; D M Hyde
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.

Authors:  M G Rosenblum; A Riso; J U Gutterman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.

Authors:  Y Nosoh; T Toge; K Niimi; M Nishiyama; N Hirabayashi; K Nakanishi; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1987-05

7.  Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata.

Authors:  E K Cardamakis; I G Kotoulas; D P Dimopoulos; E N Stathopoulos; J T Michopoulos; V A Tzingounis
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

8.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

9.  Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients.

Authors:  W Digel; G Zahn; G Heinzel; F Porzsolt
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Biological therapy of cancer.

Authors:  K A Foon
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.